Estimation of Perioperative Atelectasis
A Comparison Between Two Methods for Estimating the Extent of Perioperative Atelectasis
1 other identifier
observational
30
1 country
1
Brief Summary
This study will compare an oxygenation test based on arterial blood gas analysis with computed tomography for estimating the extent of atelectasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2017
CompletedFirst Posted
Study publicly available on registry
November 24, 2017
CompletedStudy Start
First participant enrolled
December 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2018
CompletedOctober 12, 2018
October 1, 2018
9 months
November 19, 2017
October 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Atelectasis area
Atelectasis area as studied by computed tomography
30 min after emergence from anesthesia
Secondary Outcomes (1)
Pulmonary shunt estimated by a standardised oxygenation test
30 min after emergence from anesthesia
Eligibility Criteria
Patients fulfilling inclusion and exclusion criteria while attending the day case department of Köping county hospital in Region Västmanland.
You may qualify if:
- American Society of Anesthesiology (ASA) class I-II.
- Non-abdominal day case surgery under general anesthesia.
- Patients enrolled in study registered in ClinicalTrials with NCT ID.
You may not qualify if:
- Arterial oxygen saturation (SpO2) \<90 % with 40% Venturi mask.
- Unstable postoperative condition needing immediate treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Västmanlands sjukhus Köping
Köping, Västmanland County, 73181, Sweden
Biospecimen
Arterial blood gases
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lennart Edmark, M.D., Ph.D.
Region Västmanland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 19, 2017
First Posted
November 24, 2017
Study Start
December 4, 2017
Primary Completion
August 28, 2018
Study Completion
August 28, 2018
Last Updated
October 12, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data will be available within 6 months of study completion.
- Access Criteria
- Data access requests will be reviewed by the board of the local clinical research center in Region Vastmanland. Requestors will be required to sign a Data Access Agreement.
De-identified individual participant data for all primary and secondary outcome will be available.